Inhibikase Therapeutics, Inc.
IKT
Nasdaq
Manufacturing
Chemicals
$1.70
▲
$0.01
(0.59%)
Mkt Cap: 223.80 M
Price
$1.70
Mkt Cap
223.80 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Price History
Financial Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 260,501.0 | 0.0 | 123,440.0 | 3.10 M |
| Net Income | -48.26 M | -19.03 M | -27.52 M | -18.05 M | -14.79 M |
| EPS (Diluted) | -0.49 | -3.57 | -1.16 | -0.72 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -51.97 M | -20.09 M | -28.59 M | -18.13 M | -14.77 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 29.79 M | 13.62 M | 17.21 M | 12.03 M | 11.36 M |
| SG&A Expenses | 23.56 M | 6.73 M | 11.38 M | 6.22 M | 6.51 M |
| D&A | — | — | — | — | — |
| Interest Expense | 3.72 M | 1.06 M | 1.07 M | 74,453.0 | 19,923.0 |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 181.20 M | 14.51 M | 98.60 M | 24.94 M | 42.47 M |
| Total Liabilities | 8.30 M | 3.53 M | 3.73 M | 3.90 M | 4.05 M |
| Shareholders' Equity | 172.90 M | 10.98 M | 94.87 M | 21.04 M | 38.42 M |
| Total Debt | — | 381,784.0 | — | — | 248,911.0 |
| Cash & Equivalents | 178.80 M | 9.17 M | 56.50 M | 7.19 M | — |
| Current Assets | 180.11 M | 14.21 M | 98.45 M | 24.37 M | — |
| Current Liabilities | 8.30 M | 3.44 M | 3.73 M | 3.70 M | 4.05 M |
{"event":"ticker_viewed","properties":{"ticker":"IKT","listing_kind":"stock","pathname":"/stocks/ikt","exchange":"Nasdaq","country":"US"}}